Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Nutriband Inc
(NQ:
NTRB
)
5.410
-0.440 (-7.52%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Nutriband Inc
< Previous
1
2
3
4
Next >
Nutriband Inc. to Present at The Microcap Conference Atlantic City January 30th through February 1st
January 29, 2024
Via
ACCESSWIRE
Nutriband CEO Publishes Letter to Shareholders
January 26, 2024
Via
ACCESSWIRE
Nutriband Signs Commercial Development and Clinical Supply Agreement With Kindeva Drug Delivery for Aversa(TM) Fentanyl, an Abuse Deterrent Fentanyl Patch
January 05, 2024
Via
ACCESSWIRE
Nutriband Inc. Expands its AI Kinesiology Tape Portfolio with the Launch of AI Tape Heating and Cooling
November 28, 2023
Via
ACCESSWIRE
Nutriband Inc. Signs Supplier Agreement With KT Tape, the World Leader in Kinesiology Tape
November 08, 2023
Via
ACCESSWIRE
Nutriband Announces Issuance of U.S. Patent for Transdermal Abuse Deterrent Technology
September 20, 2023
Via
ACCESSWIRE
Nutriband Inc. Receives Five Nominations in the Pharma Industry Awards 2023
September 12, 2023
Via
ACCESSWIRE
Nutriband Inc. Announces Donovan McNabb as AI Tape Brand Ambassador
August 30, 2023
Via
ACCESSWIRE
Nutriband’s Aversa(TM) Buprenoprhine May Reach Peak Annual Sales 0f $70-130 Million Based on Market Assessment by Leading Healthcare Consulting Firm
October 11, 2023
Via
ACCESSWIRE
Nutriband’s Innovative Patent Breaks New Ground in Transdermal Medications
September 20, 2023
Via
Get News
Topics
Intellectual Property
Exposures
Intellectual Property
Nutriband Unveils Groundbreaking Innovation in Transdermal Medications
September 20, 2023
ORLANDO, FL / September 20, 2023 (PlatoData via 500NewsWire) -- Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW), a leading developer of transdermal pharmaceutical products, proudly announces the issuance...
Via
TheNewswire.com
Topics
Intellectual Property
Exposures
Intellectual Property
Nutriband Announces Issuance of U.S. Patent for Transdermal Abuse Deterrent Technology
September 20, 2023
Patent issuance expands U.S. patent portfolio for AVERSA™ transdermal abuse deterrent technology Orlando, FL – September 20, 2023 – Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW), a developer of...
Via
FinancialNewsMedia
Topics
Intellectual Property
Exposures
Intellectual Property
Nutriband Inc. (NASDAQ: NTRB) Leading the Way in Friday Trading Based on Percentage Gain
July 14, 2023
Via
Investor Brand Network
Nutriband Increases Existing Credit Line to $5 Million USD for the Development of its AVERSA(TM) Platform Towards FDA Submission
July 14, 2023
Via
ACCESSWIRE
Nutriband Inc. (NASDAQ: NTRB) Near the Top of Equities by Percentage Gain on 5/31
May 31, 2023
Via
Investor Brand Network
Demand for Abuse Deterrent Formulation Technology Skyrocketing as Opiate Abuse is on the Rise
September 20, 2023
EQNX::TICKER_START (NASDAQ:NTRB),(NASDAQ:CMND),(NASDAQ:MNMD),(NYSE:CYBN),(NYSE:LLY) EQNX::TICKER_END
Via
FinancialNewsMedia
Topics
Death
Intellectual Property
Exposures
Death
Intellectual Property
Nutriband Inc. Reports Second Quarter 2023 Financial Results and Provides Business Update
September 11, 2023
Via
ACCESSWIRE
Nutriband Inc. Launches AI Tape Brand Direct-to Consumer Offerings
July 27, 2023
Via
Get News
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Nutriband Inc. Launches AI Tape Brand Direct-to Consumer Offerings
July 27, 2023
ORLANDO, FL / PlatoData via 500NewsWire / July 27, 2023 / Nutriband Inc. (the “Company”)(NASDAQ:NTRB)(NASDAQ:NTRBW), a developer of transdermal pharmaceutical products, today announced the launch of...
Via
TheNewswire.com
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Nutriband Inc. Launches AI Tape Brand Direct-to Consumer Offerings
July 27, 2023
Via
ACCESSWIRE
Nutriband Receives Notice of Allowance for U.S. Patent Covering Transdermal Abuse Deterrent Technology
June 23, 2023
Via
ACCESSWIRE
Nutriband to Attend 2023 BIO International Convention
May 10, 2023
Via
ACCESSWIRE
Nutriband Inc. Reports Revenue Up 46% in Fiscal 2023
April 27, 2023
Via
ACCESSWIRE
Nutriband Inc. to Present at the Planet MicroCap Showcase: VEGAS 2023 on Wednesday, April 26, 2023
April 19, 2023
Via
ACCESSWIRE
Nutriband With Kindeva Drug Delivery Select Aversa(TM) Fentanyl Abuse Deterrent Formulation for Commercial Scale Manufacturing Process Development
April 04, 2023
Via
ACCESSWIRE
Nutriband Secures $2 Million Line of Credit Financing Facility to be Used for Commercialization of AVERSA(TM) Abuse-Deterrent Transdermal Technology
March 28, 2023
Via
ACCESSWIRE
Nutriband Inc Joins Webull Corporate Communications Service Platform
March 08, 2023
Via
ACCESSWIRE
Nutriband COO Alan Smith Ph.D. Selected for FDA Center for Research on Complex Generics Stakeholder Expert Committee
March 02, 2023
Via
ACCESSWIRE
Nutriband Inc. to File for Product Distribution Permit in South America with Ecuador's Health Register
February 15, 2023
Via
ACCESSWIRE
Nutriband Inc. to Present at the 2023 Transdermal and Microneedle Conference
January 24, 2023
Via
ACCESSWIRE
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.